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Abstract: Hypoxia during birth is one of the leading childhood mortality worldwide and results in many neurodisabled 
survivors. Several lines of evidence demonstrated that reactive oxygen species are the final step in the metabolic 
disorders produced by a deficit of oxygen. However, any specific therapy has been effective to ameliorate the 
devastating consequences of perinatal asphyxia. In the last few years, the Thioredoxin Family Protein has emerged as a 
key player in the regulation of the redox state of the cells in normal and pathological conditions. This review summarizes 
new insight of the role of Trxs, Prxs and Grxs in physiopathology of perinatal asphyxia.  
Keywords: Trxs protein family, Perinatal asphyxia, Neuroprotection, Redox regulation, Central nervous system, 
Retina. 
1. PERINATAL ASPHYXIA 
1.1. Overview 
Perinatal asphyxia (PA) is characterized by an 
acute or subacute brain injury due to asphyxia and is 
considered one of the most frequent causes of 
morbidity and mortality in term and pre-term neonates, 
accounting for 23% of neonatal deaths globally [1]. As 
many as a million deaths worldwide might be caused 
by PA. Following PA, approximately 45% of newborns 
die and 25% have permanent neurological deficits 
including cerebral palsy, mental retardation, 
developmental disability, learning disabilities, visual 
impairments, hearing problems, and different issues in 
school readiness [2]. 
During early development, brain injury results in 
significant damage in different areas of the central 
nervous system (CNS) such as: cortex, hippocampus, 
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neostriatum, cerebellum and substantia nigra [3]. The 
type and distribution of human brain lesions differ 
markedly between premature and term newborns, likely 
as a consequence of the stage of brain maturation and 
subsequent regional vulnerability, as described in 
several previous studies [4-6]. The neonatal brain, with 
its high concentrations of unsaturated fatty acids, high 
rate of oxygen consumption, low concentrations of 
antioxidants, and availability of redox-active iron, is 
particularly vulnerable to oxidative damage [7]. 
1.2. Models of Perinatal Asphyxia 
Different model of PA has been used for many 
laboratories in the world. One of them is a murine 
model of PA. In this model uterus horns are isolated 
through an abdominal incision and placed in a water 
bath at 37°C during different period of time. According 
of the rate of survival, PA is classified in: mild PA (15 
minutes, 100 % of survival), moderate (19 minutes of 
PA, 50 % of survival) and severe (20 minutes of PA, 10 
% of survival). Following PA, uterus horns are opened, 
pups are removed and stimulated to breathe by 
performing tactile intermittent stimulation with pieces of 
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medical wipes until regular breathing was established 
and then animals were left to recover for 1h under a 
heating lamp. When their physiological conditions 
improved, they are given to surrogate mothers that had 
delivered normally within the last 24h. This PA model 
has three main advantages: first, it mimics the asphyxia 
just in the moment of delivery; second, it allows for the 
studying of both the short- as well as the long-term 
effects, since it is a non-invasive procedure; and third, 
it is easily reproducible across laboratories. The most 
obvious and serious short-term consequence of PA 
observed within this model is the mortality. Asphyxia 
period longer than 20 min generates an ATP deficit that 
leads to the consequent activation of anaerobic 
glycolysis and the accumulation of extracellular 
acidosis in the extracellular compartments [8]. 
Prolonged PA leads to an increase in expression of the 
hypoxia inducible factor (HIF-1) and a decrease of 
transcription and translation in general terms [9]. Re-
oxygenation is associated with cell death, probably 
induced by glutamate over-activation and excessive 
reactive oxygen species (ROS) release [8, 9]. Rats 
subjected to asphyxia for 20 min at 37°C, and 
monitored by microdialysis, showed chronic defects in 
neurotransmitters, such as a decrease in dopamine, 
aspartate and glutamate release [9]. In addition, an 
increase in nitric oxide (NO) levels in the neostriatum 
and neocortex, both at short- and long-term periods 
was extensively described [10].  
Long term consequences after 30 days of PA 
include modifications in cytoskeletal organization [11, 
13]. After 6 months of PA proteins misfolding triggers 
an increment in protein ubiquitination levels, and 
synaptic degeneration [9, 11]. Moreover, different 
behavioral deficits such as exploration of new 
environments, spatial reference and working memory 
were observed 3 months after PA [12]. However, this 
PA model fails in the proper determination of the exact 
grade of neuronal damage since the PA is induced 
when rats do not have the brain totally developed and 
neurons are more resistant to the oxygen deprivation. 
Cerebral hypoxia-ischemia in 7-day-old rats is another 
murine model of PA frequently used [14, 15]. Basically 
consists in the ligation of the right common carotid 
artery, which remains occluded permanently. Whereas 
the cerebral blood flow normalizes rapidly, this 
produces an ischemic condition in the brain, which 
eventually leads to a focal hypoxia. This focal hypoxia 
is followed by exposure of rat pup to an anoxic 
environment for 3 minutes causing a global hypoxia. 
This model displays some features that do not correlate 
to the cases of PA suffered during human delivery. 
First, at postnatal day 7 the rat is lissencephalic, in 
contrast to the gyrencephalic human brain [16]. Also, 
under the model conditions, ligation of the common 
carotid artery leads to unilateral regional reduction of 
cerebral blood flow; thus, the distribution of the brain 
injury caused by the experimental model does not 
correspond to human cases of severe hypoxic-
ischemic encephalopathy [15]. The multi-organ 
involvement, one of the main characteristic after severe 
clinical asphyxia, is not seen after exposure to the 
experimental model. However, this model presents 
several advantages: (a) low-cost; (b) easily 
reproducible; (c) high rate of long-term survival (90 %), 
allowing the evaluation of neurological functional and 
neuropathological outcomes; (d) postnatal day 7, the 
rat’s brain corresponds histologically to that of a near-
term human fetus of 32-34 weeks, meaning that the 
cerebral cortical neuronal layering is complete, the 
germinal matrix is involuting, and white matter has 
undergone some myelination [17, 18]. (Table 1) 
Table 1: Comparison Among Main Features of Murine 
Perinatal Asphyxia Model 
 Global Perinatal Asphyxia Global Hypoxia-Ischemia 
Procedure 
Non invasive. Place 
animal in water bath 
at 37 C. 
Easily reproducible 
Invasive. 
-Ligation of the right common 
carotid artery, which remains 
occluded 
-Exposure of rat pup to an 
anoxic environment for 3 
minutes causing a global 
hypoxia. 
Easily reproducib 
Age of pups New born 7 days old 
Rate of 
survival 
Related to the grade 
of asphyxia (100 % 
in mild asphyxia 3% 




Related to the grade 







Grade of brain damage 
Experimental 
possibilitie 
Short and long term 




histologically to a pre 
term human fetus of 
28-30 weeks 
Corresponds histologically to 
that of a near-term human 
fetus of 32-34 weeks, 
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1.3. Physiopathology 
Different mechanisms of injury have been proposed 
for the immature brain versus the adult brain. Most 
obvious difference is that apoptotic mechanisms are 
several-fold more pronounced in immature animals 
[19]. Substantial body of evidences, suggest that the 
developing brain shows a marked susceptibility to both 
changes in redox regulation and neuronal apoptosis, 
which may be related with this age-dependent injury 
vulnerability [20-24].  
Mechanisms that cause neurological damage after 
PA might divided schematically into three metabolic 
phases [25-27]. Hypoxia leads to primary energy failure 
(phase 1). Shortly after re-oxygenation, aerobic 
metabolism is re-established (phase 2). However, as a 
result of a cascade of cellular mechanisms [28, 29], 
after 6  –  24 hours’ mitochondrial energy production 
begins to fail one more time. This secondary energy 
failure (phase 3) is induced for 24  –  48 hours after the 
hypoxic event. Damage that occurs during phase 3 is 
considerable and leads to deep cellular alterations [30]. 
Although many modifications induced by PA are related 
to biological reactions that result in partial recovery, PA 
also generates over-expression of several metabolic, 
molecular and cell cascade pathways, extending the 
energy deficit and redox imbalance, associated with 
further neuronal damage, to either apoptosis (with 
several associated genes such as Bcl2, Bax among 
others) or necrosis. Molecular cascades involved in the 
removal of damaged cells implying activation of 
ubiquitination, peroxisome, and caspases pathways.  
On the other hand, redox imbalance is strongly 
connected with re-oxygenation after PA, resulting in 
both over-activation and inactivation of a number of 
buffering enzymes; including those modulating 
mitochondrial activity [31, 32]. Finally, resuscitation 
may even imply hyperoxemia, leading to a further 
production of ROS and redox imbalance, worsening 
brain injury [31, 32].  
Finally, neuroimaging studies has shown that brain 
injury evolves over days, if not weeks [33], which has 
been substantiated in different animal models [34]. If 
time permits, various therapeutic interventions may be 
attempted as the injury evolves [35]. Clinical 
observation of babies with asphyxia and extensive 
laboratory research with experimental models led to a 
heuristic model in which hypoxia-ischemia triggers a 
delayed series of events that lead to brain cell death 
[36, 37]. This period of latent interval suggested that 
post-insult interventions could be protective if started 
on time [36]. Being able to complement these findings 
with those regarding the elucidation of brain injury 
mechanisms could enable the identification of new 
therapeutic targets.  
2. REDOX REGULATION OF THIOREDOXIN 
PROTEIN FAMILY DURING PERINATAL ASPHYXIA 
BRAIN INJURY 
2.1. Central Nervous System  
Reperfusion after an ischemic event leads to an 
increased production of ROS [39, 40], that have been 
proposed as causative agent for the death and 
degeneration of neurons following the insult [8, 40-42]. 
As we describe above, we have previously shown that 
Trxs family (and related) proteins are distributed in a 
wide region and cell-type specific manner in the rat and 
mouse CNS [38, 43], implying specific functions and a 
complex crosstalk between the Trxs family members. 
In addition, not all areas of the brain are equally 
vulnerable to hypoxia-ischemia. Among the most 
vulnerable areas are the superior brainstem, 
cerebellum, white matter and subcortical structures 
supplied by the distal branches of deep and superficial 
penetrating blood vessels, cerebral white matter at the 
zones between the major cerebral artery territories, 
CA1 region of the hippocampus, and neocortical layers 
3, 5, and 6 [44-46] and retina. 
Although no studies on Trxs family proteins in PA 
have been published, both the release of ROS and 
RNS have been demonstrated under these conditions 
[8], potentially leading to the deregulation of redox 
signaling, which could be responsible for the induction 
of apoptosis and de-differentiation in the CNS 
associated with long-term neurological deficits. The 
disruption of redox control or generally, the generation 
of ROS [47, 48] by uncoupling of the mitochondrial 
chain [49] and inflammation [50, 51] were described as 
the most destructive causes of hypoxia/ischemia and 
reoxygenation injury. 
Grx2-overexpressing HEK293 and HeLa cells 
exposed to hypoxia and reoxygenation showed less 
oxidative damage and increased survival and 
proliferation rates compared to wild-type controls [52]. 
Besides the anti-apoptotic function of mitochondrial 
Grx2a [53, 54], cytosolic Grx2c was recently shown to 
be essential for embryonic brain development. 
Zebrafishes with silenced expression of the 
oxidoreductase were characterized by the loss of the 
all types of neurons due to apoptosis and a developed 
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axonal scaffold [55]. This data suggests that the 
isoforms of Grx2 could be crucial for the long-term 
regeneration of physiological redox signaling and the 
recovery of the affected tissues. 
Previous studies have shown that the Trx family of 
proteins contributes to mechanisms of brain tolerance 
in early periods after exposure to stress [56, 87]. Cells 
have developed response mechanisms to cope with 
these low oxygen concentrations. HIF-1 and 2 
constitute transcription factors that regulate the 
expression of more than 180 genes under hypoxic 
conditions [58]. The HIF-1 target ATIA (anti-TNFα-
induced-apoptosis) was shown to protect cells against 
hypoxia-induced apoptosis via Trx2 and the generation 
of ROS [59]. Moreover, hypoxia-induced mitochondrial 
ROS are essential for HIF activation [60, 61], regulate 
inflammatory responses via interleukin (IL-6) [62], and 
apoptosis via p38 phosphorylation [63]. Other studies 
suggested that over-expression of Trx1 leads to 
elevated HIF-1α levels in cells cultured under both 
normoxic and hypoxic conditions, whereas inhibition of 
TrxR1 activity blocked the activation of HIF-1α [64]. 
Trx1 leads to an induction of HIF-1α, possibly by 
activating Akt [65]. Trx1 might also be involved in 
depleting HIF-1α levels upon reoxygenation [66]. 
Hypoxic insults induce molecular and cellular 
changes, affecting cell morphology, cell polarity, 
osmoregulation, protein synthesis and the release of 
neurotransmitters [67, 68]. The reoxygenation phase 
causes rapid changes in the redox properties of the 
affected tissue and an increase in the cytokine and 
chemokine levels, as well as the infiltration of immune 
cells [69]. Not surprisingly, members of the Trx family 
protect against ischemic injuries. Over-expression of 
Trx1, Grx1, Grx2, and Prx2 attenuate ischemic damage 
of neurons [70-73]. Recently our group studied the 
expression and distribution of Trx family and related 
protein in the CNS. Trxs, Grxs and Prxs displayed a 
complex expression pattern following hypoxia/ischemia 
and reoxygenation event (Figure 1). Trx1 and Grx2 as 
late as 60 days after hypoxia/ischemia were expressed 
consistently. Over expression and silencing of these 
proteins in SH-SY5Y cells subjected to hypoxia-
reoxygenation showed that these proteins are required 
to maintain the normal neuronal phenotype. [74].  
2.2. Retina 
Retina is a tissue that undergoes high levels of 
stress due to its exposure to elevated oxygen levels 
and different light intensities [75]. Ganglion cells are the 
ones in charge of sending the visual input to the brain 
(visual cortex). This layer expresses every protein 
belonging to the Trx family proteins [38] and over 
expression of Trx1 in retinal ganglion cells increases 
their survival after glutamate/buthionine sulfoximine 
treatment. In addition, Trx1 levels decreased after 
glaucoma induction and retinas that over expressed 
Trx1 and Trx2 showed a reduced loss of retinal 
ganglion cells after glaucoma induction [76]. On the 
other hand, retinal pigment epithelium (RPE) cells are 
located near the choroidal capillaries, making them 
particularly susceptible to ischemia or hypoxia [77]. 
Sugano et al. [78] shows that Trx2 has a protective 
effect in ARPE-19 cells treated with 4-hydroxynonenal 
(4-HNE) or C2-ceramide. Over expression of Trx2 
reduced cell death induced by both agents in low 
concentrations. Moreover, Trx2 played a key role in cell 
viability through regulation of mitochondrial metabolic 
activity and Hsp70 expression 
 
Figure 1: Scheme showing the time course of the expression of the Trx protein family after PA.  
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On other hand, transgenic mice that express human 
Trx1 are less susceptible to light induced retinal 
damage [79]. Consistent with this view, Trx-1 
expression is reduced after retinal damage [80], while 
Prx6 is also diminished in cell cultures submitted to a 
hypoxia event [81]. Caprioli et al. [82] reported a 
decrease in Trx1 levels more pronounced at 5 weeks 
after intra ocular pressure (IOP). In addition, Trx1 is 
also down-regulated after IOP in a rat glaucoma model, 
whereas its overexpression after IOP leads to an 
attenuated cell death [83]. The administration of N-
methyl-D-aspartate (NMDA) to mammalian eyes 
stimulates glutamate receptors and induces retinal 
damage mimicking retinal ischemia and glaucoma. An 
intravitreous Trx1 injection effectively attenuates retinal 
cell damage induced by NMDA [84].  
2.3. Inflammatory Mediated Regulation During 
Oxygen Homeostasis Restoration 
Studies on the hypoxia signaling pathway have 
helped the concept that hypoxia can induce 
inflammation gain general acceptance. In persons with 
acute mountain sickness, for example, levels of 
circulating pro-inflammatory cytokines increase and 
vascular leakage causes pulmonary or cerebral edema. 
Hypoxia signaling and members of the nuclear factor 
κB (NF-κB) family of transcription factors regulate 
inflammation and orchestrate immune responses to 
achieve tissue homeostasis [85]. Members of this 
family interact with members of the HIF pathway in 
ways that link inflammation to hypoxia (Figure 2). 
Ischemia reperfusion activates NF-κB in epithelial 
cells, which in turn increases the production of tumor 
necrosis factor α (TNF-α), a pro-inflammatory cytokine, 
but simultaneously attenuates epithelial apoptotic 
hypoxic activated pathways. These pathways were 
related with the Thioredoxin protein family [86, 87]. 
Choksi et al. [57] reported the identification of an NF-
kB-independent ATIA (anti-TNFα-induced apoptosis)-
Trx2 (Trx2) axis that inhibits TNFα- and hypoxia-
induced apoptosis directly through elimination of 
excessive ROS. Current paradigm for inhibition of 
TNFα-induced apoptosis centers on NF-kB, which 
inhibits caspases and prevents prolonged JNK 
activation. In addition, the anti-apoptotic effect of NF-kB 
also was suggested to associate with the elimination of 
excessive ROS. In the same report, Choksi et al. [57] 
has shown that ATIA (anti-TNF α-induced apoptosis) 
inhibits TNFα-induced apoptosis independently of NF-
kB through Trx2-mediated elimination of excessive 
ROS. These findings provide a novel hypothesis for 
inhibition of apoptosis induced by TNFα and other 
death signals by directly controlling ROS accumulation. 
The pleiotropic inflammatory cytokine TNFα regulates 
immune responses, inflammation, proliferation, and cell 
death (apoptosis and necrosis), and its regulation of 
apoptosis is mainly mediated by its membrane receptor 
1 (TNF-R1). Upon TNFα stimulation, TNF-R1 trimer 
 
Figure 2: Schematic illustration of ATIA serving as a Link between inflammation and hypoxia: The ATIA-TRX2 axis 
inhibits apoptosis induced by both TNFα and low O2 through elimination of excessive ROS on mitochondria. This scenario 
rescues parenchymal cells from apoptosis. ATIA activity may be a key regulator in carcinogenesis because tumor cells usually 
take advantage from normal tissue under hypoxic conditions. Blockade of antitumor TNF- α cytotoxicity. 
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recruits multiple adaptors such as, TRAF2, TRAF5, 
RIP1, cIAP1 and cIAP2 and other modulators or 
regulators such as Miz1 and the linear ubiquitin chain 
assembly complex [88, 89], 
2.4. Thioredoxin, Hypoxic-Ischemic Brain Injuries 
and Cognitive Alterations 
The hippocampus is commonly associated with 
learning and memory processes in mammals [90]. 
Previous studies have demonstrated that hypoxic-
ischemic brain injuries can induce hippocampal neuron 
loss, which is implicated in spatial learning and memory 
deficits [91-93]. It has been demonstrated that transient 
bilateral common carotid arteries occlusion (BCCAO) 
can destroy more than 50% of hippocampal CA1 
neurons [94] inducing learning and memory 
deficiencies tested in the Morris water maze [95, 96]. 
Redox regulatory proteins, such as Trxs, play a key 
role in the cellular response to redox imbalance, 
against brain damage induced by hypoxic-ischemic 
injuries [38]. Acute hypoxia leads to long-lasting 
behavioral consequences (motor, emotional and 
cognitive dysfunctions) in adult asphyctic rats [12]. 
However, only few works have studied the role of redox 
imbalance in the origin of behavioral alterations 
induced by hypoxic-ischemic injuries. 
Regarding to Trx1, endogenous Trx1 production is 
induced by cerebral ischemia where it is responsible for 
alleviation of oxidative damage. Exogenously 
administered recombinant human Trx1 (rhTrx1) can 
penetrate the blood brain barrier and exert a 
neuroprotective effect on injured neurons by the middle 
cerebral artery occlusion (MCAO) [97]. RhTrx1 may 
also promote neurogenesis and facilitate long-term 
recovery following bilateral common carotid artery 
occlusion (BCCAO). Recently, Tian et al. [98] have 
investigated the role of rhTrx1 in neurogenesis and its 
potential effect on learning and memory deficits 
measured in the Morris water maze following the 
BCCAO mouse model. Mice subjected to BCCAO 
treated with rhTrx1 before reperfusion showed 
shortened escape latencies in the learning phase and 
improvements in the spatial memory test. Moreover, 
rhTrx1 was effective in promoting neurogenesis in the 
dentate gyrus after cerebral ischemia and facilitating 
cognitive recovery of treated mice [99]. Previous 
studies have demonstrated that hippocampal 
neurogenesis could facilitate long-term potentiation and 
improve memory and learning [100, 101]. Hence, 
facilitation of endogenous neurogenesis could be a 
promising regenerative strategy for ischemic stroke 
treatment [100]. 
In other recent work, Yang et al. [101] studied the 
role of Trxs in neurodegenerative changes of rats 
subjected to chronic exposure to an intermittent 
hypoxia (CIH) model. The most notable alterations 
were increased apoptosis in the CA1 region of the 
hippocampus and adjacent cortex, as well as 
substantial neuropsychological impairments of spatial 
learning in the Morris water maze. CIH-rats showed 
impaired spatial learning and memory in the water 
maze (longer latencies to reach the target platform, 
reduced numbers of passes over the target platform, 
and smaller percentage of time spent in the target 
quadrant). Trx mRNA and protein levels were 
significantly decreased in the CIH-hippocampus; 
meanwhile, an elevated apoptosis of hippocampal 
neurons of rats exposed to CIH was found. Rats, which 
displayed better performance in the spatial memory 
test, also showed higher levels of the Trx mRNA and 
protein in the hippocampus and lower number of 
apoptotic cells in the hippocampus [101]. Hence, Trx 
deficit may play a significant role in the impaired spatial 
learning and memory in rats exposed to CIH and this 
alteration may trigger the apoptosis of hippocampal 
neurons. 
New studies are necessary to understand the 
relationships between redox system regulations in 
cognitive alterations after neuronal damage induced by 
hypoxic-ischemic episodes. 
3. CONCLUSIONS 
Several lines of evidences propose a key role of 
Trxs in the physiopathology of the brain ischemia insult. 
In addition, recently we have demonstrated that Trx-1 
and Grx-2 have a key role on the different steps of the 
nervous cells differentiation. Therefore, Trx-s protein 
family appears a novel actor in the regulation of the 
mechanism involved in cell damage during PA. 
4. FUTURE DIRECTIONS 
Future experiments should be carried out to obtain 
new insights about Trx-s protein family function in the 
rescue of the nervous cells subjected to anoxic-hypoxic 
in order to design new therapeutic tools. These studies 
might introduce new insights, extremely useful to 
develop new therapeutic tools for PA and its 
complications.  
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